Solgate Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 5

Solgate General Information

Description

Operator of a biotechnology company intended to develop drugs against the solute gates to cure disease. The company focuses on membrane transporters known as solute carrier proteins and applies methods from chemistry, cell biology, and advanced analytics, developing an internal pipeline in specific therapeutic indications, including immunity, enabling pharmaceutical companies to find treatments for challenging diseases.

Contact Information

Website
www.solgate.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • IST Park, Plöcking 1
  • Klosterneuburg, Niederosterreich 3400
  • Austria
+43 0664
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • IST Park, Plöcking 1
  • Klosterneuburg, Niederosterreich 3400
  • Austria
+43 0664

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Solgate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 26-Feb-2021 Completed Generating Revenue
To view Solgate’s complete valuation and funding history, request access »

Solgate Patents

Solgate Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026202277-A1 New heterocyclic compounds reducing the tasl protein level Pending 26-Mar-2025
WO-2026202291-A1 New heterocyclic compounds reducing the tasl protein level Pending 26-Mar-2025
WO-2026202295-A1 New heterocyclic compounds reducing the tasl protein level Pending 26-Mar-2025
AU-2025261993-A1 New heterocyclic compounds reducing the tasl protein level Pending 24-Apr-2024
WO-2025224270-A1 New heterocyclic compounds reducing the tasl protein level Pending 24-Apr-2024 C07D215/52
To view Solgate’s complete patent history, request access »

Solgate Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Solgate Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Austria Wirtschaftsservice Venture Capital Minority
Lansdowne Capital PE/Buyout Minority
S-Quad Handels- und Beteiligungs Family Office Minority
Wlanholding Family Office Minority
Xista Science Ventures Venture Capital Minority
To view Solgate’s complete investors history, request access »

Solgate FAQs

  • When was Solgate founded?

    Solgate was founded in 2020.

  • Where is Solgate headquartered?

    Solgate is headquartered in Klosterneuburg, Austria.

  • What is the size of Solgate?

    Solgate has 31 total employees.

  • What industry is Solgate in?

    Solgate’s primary industry is Biotechnology.

  • Is Solgate a private or public company?

    Solgate is a Private company.

  • What is the current valuation of Solgate?

    The current valuation of Solgate is .

  • What is Solgate’s current revenue?

    The current revenue for Solgate is .

  • Who are Solgate’s investors?

    Austria Wirtschaftsservice, Lansdowne Capital, S-Quad Handels- und Beteiligungs, Wlanholding, and Xista Science Ventures have invested in Solgate.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process